Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

NCT05080270 is registered in ClinicalTrials.gov with FibroBiologics as lead sponsor.

NCT NCT05080270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05080270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis
Lead sponsor
FibroBiologics
Phase
Phase 1
Overall status
Completed
Start date
September 21, 2020
Completion date
June 8, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis, relapsing-remitting